4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with Benign Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Czoli, CD; Hammond, D | 1 |
1 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Benign Neoplasms
Article | Year |
---|---|
Carcinogen Exposure among Canadian Tobacco Users: Changes in NNK Exposure from 2007-2009 through 2012-2013.
Topics: Adolescent; Adult; Aged; Biomarkers; Canada; Carcinogens; Child; Child, Preschool; Cross-Sectional Studies; Environmental Monitoring; Female; Health Surveys; Humans; Male; Middle Aged; Neoplasms; Nitrosamines; Prevalence; Smoking; Tobacco Products; Young Adult | 2018 |